Pınar TULAY, Faisal FAISAL, Nedime SERAKINCI, Ruqiya PERVAIZ

Incidence of cancer in the Turkish Republic of Northern Cyprus

Background/aim: This study analyzed the incidence, trends, and common types of cancer in the Turkish Republic of Northern Cyprus (TRNC). Materials and methods: This study is based on data collected from the office of the North Cyprus Cancer Registry, Ministry of Health, for 2007 2012. Data were arranged on the basis of age group, sex, and cancer site. Age standardized incidence rates (ASRs) were estimated with the world standard population. EVIEWS (version 9) software was used for statistical analysis. Results: Of 1395 registered cases, 52.33% (730) were reported in men and 47.67% (665) in women. The crude incidence rate was 96.41 in men and 101.74 in women. The average annual ASR was 88.88 in men and 87.76 in women with the cumulative rate of 21.47% and 14.69% in men and women, respectively. The most common cancers in men were skin (ASR 15.62), prostate (ASR 11.23), bladder (ASR 11.71), lung (ASR 8.01), and colorectal cancer (ASR 7.61), while in women these were breast (ASR 24.07), thyroid (ASR 14.93), skin (ASR 10.75), colorectal (ASR 6.05), and lymphoma (ASR 4.79). Linear regression analysis confirmed rising trends for both men s (10.79, P ≤ 0.03) and women s (14.67, P ≤ 0.04) cancers. Conclusion: Our findings revealed an increasing trend of cancer incidence in the TRNC. For control and prevention, public awareness of the risk factors and proper screening programs should be recommended.

PDF

___

1. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Coleman MP. Global surveillance of cancer survival 19952009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2015; 385: 977-1010.
2. Stewart BW, Wild CP. World Cancer Report 2014. Lyon, France: IARC; 2014.
3. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010; 19: 1893-1907.
4. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis 2009; 31: 100-110.
5. WHO. World Health Statistics 2014. Geneva, Switzerland: WHO; 2014.
6. Adamson P, Bray F, Costantini AS, Tao MH, Weiderpass E, Roman E. Time trends in the registration of Hodgkin and nonHodgkin lymphomas in Europe. Eur J Cancer 2007; 43: 391- 401.
7. OECD. Health at a Glance: Europe 2014. Paris, France: OECD Publishing; 2014.
8. TRNC State Planning Organization. Statistical Yearbook. Lefkoşa, Turkish Republic Of Northern Cyprus: SPO; 2012.
9. Armitage P, Berry G, Mathews JN. Statistical Methods in Medical Research. Oxford, UK: Blackwell Science; 2008.
10. American Cancer Society. Global Cancer Facts & Figures. Atlanta, GA, USA: ACS; 2011.
11. Adams TD, Stroup AM, Gress RE, Adams KF, Calle EE, Smith SC, Hunt SC. Cancer incidence and mortality after gastric bypass surgery. Obesity 2009; 17: 796-802.
12. Doll R. Cancer Incidence in Five Continents: A Technical Report. Berlin, Germany: Springer-Verlag; 1966.
13. Boyle P, Parkin D. Statistical methods for registries. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG. Cancer Registration Principles and Methods. Lyon, France: IARC; 1991. pp. 126-158.
14. Breslow NE, Day NE. Statistical Methods in Cancer Research Volume II - The Design and Analysis of Cohort Studies. Lyon, France: IARC; 1987.
15. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
16. Clapp RW, Howe GK, Jacobs M. Environmental and occupational causes of cancer re-visited. J Public Health Policy 2006; 27: 61-76.
17. OECD. Health Data 2004. Paris, France: OECD; 2004.
18. Belpomme D, Irigaray P, Sasco AJ, Newby JA, Howard V, Clapp R, Hardell L. The growing incidence of cancer: role of lifestyle and screening detection (review). Int J Oncol 2007; 30: 1037- 1049.
19. Keyghobadi N, Rafiemanesh H, Mohammadian A, Enayatrad M, Salehiniya H. Epidemiology and trend of cancers in the province of Kerman: southeast of Iran. Asian Pac J Cancer Prev 2015; 16: 1409-1413.
20. Irigaray P, Newby JA, Clapp R, Hardell L, Howard V, Montagnier L, Belpomme D. Lifestyle-related factors and environmental agents causing cancer: an overview. Biomed Pharmacother 2007; 61: 640-658.
21. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: 359-386.
22. Ministry of Health. North Cyprus Cancer Registry. Lefkoşa, Turkish Republic Of Northern Cyprus Ministry of Health; 2013.
23. Hinçal E, Taneri B, Taneri U, Djamgoz MB. Cancer incidence in North Cyprus (1990-2004) relative to European rates. Asian Pac J Cancer Prev 2008; 9: 725-732.
24. Farazi P. Cancer trends and risk factors in Cyprus. Ecancermedicalscience 2014; 8: 1-17.
25. Afsharfard A, Mozaffar M, Orang E, Tahmasbpour E. Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study. Asian Pac J Cancer Prev 2013; 14: 6905-6911.
26. Salim EI, Moore MA, Al-Lawati J, Al-Sayyad J, Bazawir A, Bener A, Sobue T. Cancer epidemiology and control in the Arab world - past, present and future. Asian Pac J Cancer Prev 2009; 10: 3-16.
27. Karim SM, Baeshen W, Neamatullah SN, Bin B. Oral contraceptives, abortion and breast cancer risk: a case control study in Saudi Arabia. Asian Pac J Cancer Prev 2015; 16: 3957- 3960.
28. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA-J Am Med Assoc 2006; 295: 2164-2167.
29. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
30. Ron E, Schneider AB. Thyroid cancer. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer Epidemiology and Prevention. Oxford, UK: Oxford University Press; 2006. pp. 975-994.
31. Warren BS, Devine C. Breast Cancer in Men. Ithaca, NY, USA: Cornell Center for the Environment; 2001.
32. WHO. World Health Statistics. Geneva, Switzerland: WHO; 2011.
33. Amoori N, Mirzaei M, Cheraghi M. Incidence of cancers in Kuzestan province of Iran: trend from 2004 to 2008. Asian Pac J Cancer Prev 2014; 15: 8345-8349.
34. American Cancer Society. Cancer Facts & Figures 2013. Atlanta. GA, USA: ACS; 2013.
35. Lucas R. Solar Ultraviolet Radiation: Assessing the Environmental Burden of Disease at National and Local Levels. Environmental Burden of Disease Series, No. 17. Geneva, Switzerland: World Health Organization; 2010.
36. Kiriluk KJ, Prasad SM, Patel AR, Steinberg GD, Smith ND. Bladder cancer risk from occupational and environmental exposures. Urol Oncol 2012; 30: 199-211.
37. Shavers VL, Underwood W, Moser RP. Race/ethnicity and the perception of the risk of developing prostate cancer. Am J Prev Med 2009; 37: 64-67.
38. Mandair D, Rossi RE, Pericleous M, Whyand T, Caplin ME. Prostate cancer and the influence of dietary factors and supplements: a systematic review. Nutr Metab (Lond) 2014; 11: 30.
39. United States Department of Health and Human Services. Cancer Risks. Washington, DC, USA: US HHS; 2014.
40. Hamdi HK, Castellon R. Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor. Biochem Biophys Res Commun 2005; 334: 769-778.
41. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527.
42. El-Khwsky FS, Maghraby HK, Rostom YA, Abd El-Rahman AH. Multivariate analysis of reproductive risk factors for ovarian cancer in Alexandria, Egypt. J Egypt Natl Canc Inst 2006; 18: 30-34.